[Studies on thyroid hormone autoantibody (THAA) in 2 cases of Graves' disease with spuriously high free thyroxine values].
Two patients with Graves' disease treated with methimazole (MMI) showed a discrepancy between serum free T4 (FT4) values and other hormone values (especially total T4) which was due to the presence of potent binding activity to labelled T4 analogue (125I-aT4) in their serum. This activity was demonstrated to be in immunoglobulin G (IgG) with kappa light chain isotype in both patients. The binding of 125I-aT4 to their serum was inhibited by unlabelled T4 in a dose-dependent manner. Autoantibodies had almost identical binding affinity to T4 and aT4, although they precipitated more radioactivity when 125I-aT4 was used. The binding of IgG purified from patients' sera to labelled T4 or aT4 was not greater than the corresponding sera, suggesting that the thyroxine binding proteins did not interfere with the assay. Since the specific radioactivity of 125I-aT4 is almost 10 times higher than that of 125I-T4, autoantibodies can precipitate almost 10 times more radioactivity in the FT4 assay than the total T4 assay, thus leading to the spuriously high FT4 values and large discrepancy between FT4 and TT4 values.
Fukasawa
N
N
Fourth Department of Internal Medicine, Saitama Medical School, Japan.
Iitaka
M
M
Hara
Y
Y
Yanagisawa
M
M
Hase
K
K
Miura
S
S
Sakatume
Y
Y
Ishii
J
J
D000328:Adult; D001323:Autoantibodies / Q000032:analysis*; D005260:Female; D006111:Graves Disease / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis*; D008713:Methimazole / Q000627:therapeutic use; D013974:Thyroxine / Q000097:blood / Q000276:immunology*
D001323:Autoantibodies; D007074:Immunoglobulin G; D008713:Methimazole; D013974:Thyroxine